Steris PLC (N:STE)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 24, 2024 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 fourth quarter and full year financial results at 9:00 a.m. ET on May 9, 2024. The conference call can be heard live...
Apr 11, 2024 07:30 am ET
PEAK ROCK CAPITAL AFFILIATE SIGNS DEFINITIVE AGREEMENT TO ACQUIRE HUFRIEDYGROUP
AUSTIN, Texas, April 11, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has signed a definitive agreement to acquire the dental segment ("HuFriedyGroup" or the "Company") of STERIS plc (NYSE:STE) ("STERIS").
Apr 11, 2024 06:58 am ET
STERIS to Sell Dental Segment to an affiliate of Peak Rock Capital
) - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has entered into a definitive agreement to divest its Dental segment to Peak Rock Capital, a leading middle-market private investment firm, for $787.5 million...
Feb 07, 2024 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2024 Third Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 third quarter ended December 31, 2023. Revenue as reported for the quarter increased 15% to $1.40 billion compared with $1.22 billion in the...
Jan 30, 2024 04:30 pm ET
STERIS Announces Dividend of $0.52 per share
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on March 22, 2024, to shareholders of record at the close of business on...
Jan 23, 2024 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 third quarter financial results at 9:00 a.m. ET on February 8, 2024. The conference call can be heard live at...
Nov 07, 2023 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2024 Second Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 second quarter ended September 30, 2023. Revenue as reported for the quarter increased 12% to $1.34 billion compared with $1.20 billion in the...
Oct 31, 2023 06:05 pm ET
STERIS Announces Dividend of $0.52 per share
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. The dividend is payable on December 21, 2023, to shareholders of record at the close of business...
Oct 24, 2023 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2024 Second Quarter Financial Results on November 8, 2023
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 second quarter financial results at 9:00 a.m. ET on November 8, 2023. The conference call can be heard live at...
Aug 30, 2023 04:30 pm ET
STERIS to Present at the Morgan Stanley Healthcare Conference
STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York City on Wednesday, September 13, 2023.   Dan Carestio, President and CEO of STERIS will present at 8:10...
Aug 02, 2023 04:30 pm ET
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton,...
Aug 01, 2023 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2024 First Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first quarter ended June 30, 2023. Revenue as reported for the quarter increased 11% to $1.28 billion compared with $1.16 billion in the first...
Jul 26, 2023 04:30 pm ET
STERIS Raises Dividend to $0.52 per share
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per share. This represents a $0.05 increase in the dividend and the Company’s 18th consecutive year of...
Jul 19, 2023 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 first quarter financial results at 9:00 a.m. ET on August 2, 2023. The conference call can be heard live at...
Jun 20, 2023 08:01 am ET
BD to Sell Surgical Instrumentation Platform to STERIS
Divestiture Advances BD2025 Strategy to Simplify Portfolio  and Focus on Higher-Growth Markets
Jun 20, 2023 08:00 am ET
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for $540 million
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from Becton, Dickinson...
May 10, 2023 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full Year
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 fourth quarter and full year ended March 31, 2023. Revenue as reported for the quarter increased 14% to $1.38 billion compared with $1.21...
May 03, 2023 04:30 pm ET
STERIS Announces $500 million Share Repurchase Authorization and Declares $0.47 per share Dividend
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that STERIS's Board of Directors has authorized a new share buyback program for the purchase of up to $500 million of the Company's ordinary shares. Shares may be repurchased from...
May 03, 2023 04:30 pm ET
STERIS Appoints Esther M. Alegria, Ph.D. to Board of Directors
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that Esther M. Alegria, Ph.D. has been elected to the Board of Directors, effective today. “We are pleased to welcome Dr. Alegria to our Board,” said Mohsen Sohi, Chairman of...
Apr 24, 2023 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2023 Fourth Quarter and Full Year Financial Results on May 11, 2023
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 fourth quarter and full year financial results at 9:00 a.m. ET on May 11, 2023. The conference call can be heard live...
Feb 08, 2023 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2023 Third Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 third quarter ended December 31, 2022. Revenue as reported for the quarter increased 1% to $1.22 billion compared with $1.21 billion in the...
Feb 01, 2023 04:52 pm ET
STERIS Declares $0.47 per share Dividend
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable March 23, 2023 to shareholders of record at the close of business on...
Jan 25, 2023 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter financial results at 10:00 a.m. ET on February 9, 2023. The conference call can be heard live at...
Nov 09, 2022 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2023 Second Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Revenue as reported for the quarter was flat at $1.2 billion compared with $1.2 billion in the second...
Nov 02, 2022 04:30 pm ET
STERIS Declares $0.47 per share Dividend
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable December 16, 2022 to shareholders of record at the close of business on...
Oct 25, 2022 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 second quarter financial results at 10:00 a.m. ET on November 10, 2022. The conference call can be heard live at...
Aug 02, 2022 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2023 First Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 first quarter ended June 30, 2022. Revenue as reported for the quarter increased 19% to $1.2 billion compared with $968.4 million in the first...
Jul 28, 2022 04:30 pm ET
STERIS Raises Dividend to $0.47 per share
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. This represents a $0.04 increase in the dividend and the Company’s 17th consecutive year of...
Jul 20, 2022 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2023 First Quarter Financial Results on August 3, 2022
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 first quarter financial results at 10:00 a.m. ET on August 3, 2022. The conference call can be heard live at...
May 11, 2022 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 fourth quarter ended March 31, 2022. Revenue as reported for the quarter increased 39% to $1.2 billion compared with $873.5 million in the...
May 04, 2022 04:30 pm ET
STERIS Declares $0.43 per share Dividend
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.43 per share. The dividend is payable June 28, 2022 to shareholders of record at the close of business on June...
Apr 25, 2022 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2022 Fourth Quarter and Full Year Financial Results on May 12, 2022
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 fourth quarter and full year financial results at 10:00 a.m. ET on May 12, 2022. The conference call can be heard live...
Feb 08, 2022 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2022 Third Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 third quarter ended December 31, 2021. Revenue as reported for the quarter increased 49% to $1.2 billion compared with $808.9 million in the...
Jan 31, 2022 04:30 pm ET
STERIS Declares $0.43 per share Dividend
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.43 per share. The dividend is payable March 24, 2022 to shareholders of record at the close of business on...
Jan 25, 2022 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2022 Third Quarter Financial Results on February 9, 2022
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quarter financial results at 10:00 a.m. ET on February 9, 2022. The conference call can be heard live at...
Jan 03, 2022 04:15 pm ET
Evoqua Water Technologies Closes Acquisition of Renal Business from STERIS
Evoqua Water Technologies (NYSE: AQUA), an industry leader in mission-critical water treatment solutions, today announced the closing of the previously announced acquisition of the renal business historically operated by Mar Cor Purification and Cantel
Nov 02, 2021 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2022 Second Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 second quarter ended September 30, 2021. Revenue as reported for the quarter increased 58% to $1,197 million compared with $756 million in the...
Oct 28, 2021 04:30 pm ET
STERIS Declares $0.43 per share Dividend
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.43 per share. The dividend is payable December 17, 2021 to shareholders of record at the close of business on...
Oct 20, 2021 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2022 Second Quarter Financial Results on November 3, 2021
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 second quarter financial results at 10:00 a.m. ET on November 3, 2021. The conference call can be heard live at...
Aug 09, 2021 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2022 First Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 first quarter ended June 30, 2021. Revenue as reported for the quarter increased 45% to $968.4 million compared with $668.9 million in the...
Jul 27, 2021 09:07 am ET
STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 first quarter financial results at 10:00 a.m. ET on Tuesday, August 10, 2021. The conference call can be heard live at...
Jun 02, 2021 09:00 am ET
STERIS Completes the Acquisition of Cantel Medical
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and...
May 18, 2021 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Year
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 fourth quarter ended March 31, 2021. Revenue as reported for the quarter increased 6% to $873.5 million compared with $823.0 million in the...
May 11, 2021 04:30 pm ET
STERIS Announces Changes to Board of Directors
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced changes to its Board of Directors. David Lewis, Board member since 2010 has announced that he will not stand for election when his term expires on July 29, 2021. In addition,...
Apr 27, 2021 04:51 pm ET
STERIS to Host a Conference Call for Fiscal 2021 Fourth Quarter and Full Year Financial Results on May 19, 2021
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 fourth quarter and full year financial results at 11:00 a.m. ET on Wednesday, May 19, 2021. The conference call can be...
Apr 27, 2021 07:00 am ET
STERIS Announces Preliminary Financial Results for Fiscal 2021
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced preliminary financial results for its fiscal 2021 year ending March 31, 2021. The Company expects to report that revenue as reported for fiscal 2021 increased approximately 3% to...
Feb 09, 2021 02:37 pm ET
CANTEL MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD
NEW ORLEANS, Feb. 9, 2021 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE).  Under the terms of the proposed transaction, shareholders of Cantel will receive only $16.93 in cash and 0.33787 of a STERIS ordinary share for each share of Cantel that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Feb 03, 2021 07:00 am ET
STERIS Announces Leadership Succession Plan
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that Walt Rosebrough, President and CEO, has announced his intention to step down on July 29, 2021, in conjunction with the company’s Annual General Meeting. Mr. Rosebrough will...
Feb 02, 2021 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2021 Third Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 third quarter ended December 31, 2020.  Revenue as reported for the quarter increased 4% to $808.9 million compared with $774.3 million in the...
Jan 19, 2021 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2021 Third Quarter Financial Results on February 3, 2021
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 third quarter financial results at 10:00 a.m. ET on Wednesday, February 3, 2021.  The conference call can be heard...
Jan 13, 2021 07:30 pm ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Cantel Medical Corp. Buyout
Rigrodsky Law, P.A. announces that it is investigating Cantel Medical Corp. (“Cantel”) (NYSE: CMD) regarding possible breaches of fiduciary duties and other violations of law related to Cantel’s agreement to be acquired by STERIS plc (“STERIS”)...
Jan 12, 2021 04:06 pm ET
SHAREHOLDER ALERT: WeissLaw LLP Investigates Cantel Medical Corp.
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cantel Medical Corp. ("CMD" or the "Company") (NYSE: CMD) in connection with the proposed acquisition of the Company by STERIS plc ("STERIS") (NYSE: STE).  Under the terms of the merger agreement, STERIS will acquire CMD in a mixed cash-and-stock transaction, pursuant to which CMD shareholders will receive $16.93 in cash and 0.33787 of a STERIS ordinary share for each CMD share that they own, representing implied per-share merger c
Jan 12, 2021 12:29 pm ET
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cantel Medical Corporation
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors concerning the proposed acquisition of the company by Steris Plc (NYSE: STE) ("Steris"). Under the terms of the agreement, Cantel common stockholders will receive approximately $16.93 in cash and 0.33787 of a Steris ordinary share, or a total of value of approximately $84.66 per Cantel common share based on Steris's closing share price of $200.46 on January 11, 2021. The transaction is valued at approximat
Jan 12, 2021 12:21 pm ET
CANTEL ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CMD and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Cantel Medical Corp. (NYSE: CMD) breached their fiduciary duties or violated the federal securities...
Jan 12, 2021 07:12 am ET
STERIS Announces Definitive Agreement to Acquire Cantel Medical
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary.  Cantel is a global provider of infection...
Jan 07, 2021 05:14 pm ET
STERIS To Participate in Upcoming Investor Conferences
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company will be publicly webcasting presentations made by Walt Rosebrough, President and Chief Executive Officer at two investor conferences next week.  The first...
Nov 18, 2020 04:30 pm ET
STERIS Completes Acquisition of Key Surgical
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that is has completed the previously announced acquisition of Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC. “We are pleased to announce the timely...
Nov 02, 2020 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2021 Second Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 second quarter ended September 30, 2020.  Revenue as reported for the quarter increased 3% to $756.1 million compared with $736.8 million in...
Oct 20, 2020 07:00 am ET
STERIS to Host a Conference Call for Fiscal 2021 Second Quarter Financial Results on November 3, 2020
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 second quarter financial results at 10:00 a.m. ET on Tuesday, November 3, 2020.  The conference call can be heard live...
Oct 06, 2020 07:00 am ET
STERIS Expands Healthcare Consumables Offering with Acquisition of Key Surgical for approximately $850 million
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC, through a U.S. subsidiary for $850...
Aug 03, 2020 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2021 First Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2021 first quarter ended June 30, 2020.  Revenue as reported for the quarter decreased 4% to $668.9 million compared with $696.8 million in the...
Jul 22, 2020 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2021 First Quarter Financial Results on August 4, 2020
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2021 first quarter financial results at 10:00 a.m. Eastern Time on Tuesday, August 4, 2020.  The conference call can be...
May 26, 2020 07:00 am ET
STERIS Announces Second On-site Decontamination Solution for Respiratory Masks
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has issued another Emergency Use Authorization (EUA) for respirator decontamination.  The EUA enables healthcare providers to...
May 13, 2020 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2020 Fourth Quarter and Full Year
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 fourth quarter ended March 31, 2020.  Revenue as reported for the quarter increased 7% to $823.0 million compared with $768.2 million in the...
Apr 30, 2020 07:00 am ET
STERIS to Host a Conference Call for Fiscal 2020 Fourth Quarter and Full Year Financial Results on May 14, 2020
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 fourth quarter and full year financial results at 10:00 a.m. Eastern Time on Thursday, May 14, 2020.  The conference...
Apr 10, 2020 12:07 pm ET
STERIS Announces Decontamination Solution for Respiratory Masks
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for respirator decontamination.  The EUA enables healthcare providers to...
Feb 19, 2020 08:10 am ET
STERIS to Participate in the Raymond James Institutional Investor Conference
STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Raymond James Institutional Investor Conference on Monday, March 2, 2020.   Michael J. Tokich, STERIS’s Senior Vice President and Chief Financial Officer...
Feb 10, 2020 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2020 Third Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 third quarter ended December 31, 2019.  Revenue as reported for the quarter increased 11% to $774.3 million compared with $696.2 million in the...
Jan 27, 2020 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2020 Third Quarter Financial Results on February 11, 2020
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 third quarter financial results at 10:00 a.m. Eastern Time on Tuesday, February 11, 2020.  The conference call can be...
Nov 04, 2019 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2020 Second Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 second quarter ended September 30, 2019.  Revenue as reported for the quarter increased 9% to $736.8 million compared with $679.0 million in...
Oct 22, 2019 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2020 Second Quarter Financial Results on November 5, 2019
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 second quarter financial results at 10:00 a.m. Eastern Time on Tuesday, November 5, 2019.  The conference call can be...
Aug 26, 2019 04:30 pm ET
STERIS to Participate in the Morgan Stanley Global Healthcare Conference
STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Walt Rosebrough, STERIS’s President and CEO will present at 2:55 p.m. Eastern...
Aug 05, 2019 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2020 First Quarter
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 first quarter ended June 30, 2019.  Revenue as reported for the quarter increased 9% to $696.8 million compared with $638.8 million in the...
Jul 23, 2019 04:30 pm ET
STERIS to Host a Conference Call for Fiscal 2020 First Quarter Financial Results on August 6, 2019
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 first quarter financial results at 10:00 a.m. Eastern Time on Tuesday, August 6, 2019.  The conference call can be...
May 13, 2019 04:30 pm ET
STERIS Announces Financial Results for Fiscal 2019 Fourth Quarter and Full Year
- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2019 fourth quarter ended March 31, 2019.  Revenue as reported for the quarter increased 7% to $768.2 million compared with $716.0 million in the...
Apr 30, 2019 05:06 pm ET
STERIS to Host a Conference Call for Fiscal 2019 Fourth Quarter and Full Year Financial Results on May 14, 2019
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2019 fourth quarter and full year financial results at 10:00 a.m. Eastern Time on Tuesday, May 14, 2019. The conference...
Jan 22, 2019 07:25 am ET
Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Macy's, Inc. (NYSE:M), Leggett & Platt, Incorporated (NYSE:LEG), Tyler...
Oct 22, 2018 08:40 am ET
Report: Developing Opportunities within Balchem, STERIS plc, Tableau Software, Werner Enterprises, Wabco, and Weis Markets — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Balchem Corporation (NASDAQ:BCPC), STERIS plc (NYSE:STE), Tableau...
Jun 22, 2018 08:20 am ET
Research Report Identifies STERIS plc, Parker-Hannifin, Sturm, Ruger, CoBiz Financial, Black Hills, and Glacier with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of STERIS plc (NYSE:STE), Parker-Hannifin Corporation (NYSE:PH), Sturm, Ruger...
May 03, 2018 07:55 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within Sonic Automotive, STERIS plc, AquaVenture, Senseonics, Acceleron Pharma, and Steelcase — New Research Emphasizes Economic Growth
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sonic Automotive, Inc. (NYSE:SAH), STERIS plc (NYSE:STE), AquaVenture...
Apr 23, 2018 08:30 am ET
Varex Imaging Names Rosebrough To Board Of Directors
SALT LAKE CITY, April 23, 2018 /PRNewswire/ -- Varex Imaging Corporation (Nasdaq: VREX) today announced that Walter M Rosebrough, Jr. has been appointed to the company's Board of Directors, effective April 20, 2018.
Mar 21, 2018 07:40 am ET
New Research Coverage Highlights Monolithic Power, Alleghany, O'Reilly Automotive, Associated Banc-Corp, BancFirst, and STERIS plc — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Monolithic Power Systems, Inc. (NASDAQ:MPWR), Alleghany...
Feb 07, 2018 07:50 am ET
STERIS plc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 7, 2018 / STERIS plc (NYSE: STE) will be discussing their earnings results in their Q3 Earnings Call to be held on February 7, 2018 at 10:00 AM Eastern Time.
Jan 18, 2018 07:50 am ET
Analysis: Positioning to Benefit within First Midwest, MaxLinear, STERIS, Unifi, Calavo Growers, and Ellington Residential Mortgage REIT — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Jan. 18, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of First Midwest Bancorp, Inc. (NASDAQ:FMBI), MaxLinear,...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.